These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32526313)

  • 1. T
    Trichot C; Faucheux L; Karpf L; Grandclaudon M; Pattarini L; Bagot M; Mahévas T; Jachiet M; Saussine A; Bouaziz JD; Soumelis V
    J Allergy Clin Immunol; 2021 Feb; 147(2):756-759. PubMed ID: 32526313
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.
    Charvet E; Bourrat E; Hickman G; Donadieu J; Bellanné-Chantelot C; Jachiet M; Bouaziz JD; Bagot M; Cassius C
    Clin Exp Dermatol; 2021 Oct; 46(7):1334-1335. PubMed ID: 33864281
    [No Abstract]   [Full Text] [Related]  

  • 3. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
    Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
    Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute infections in atopic dermatitis: a clue for a pathogenic role of a Th1/Th2 imbalance?
    Lacour M
    Dermatology; 1994; 188(4):255-7. PubMed ID: 7514908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome.
    Sogkas G; Hirsch S; Jablonka A; Witte T; Schmidt RE; Atschekzei F
    Clin Immunol; 2020 Jun; 215():108452. PubMed ID: 32360519
    [No Abstract]   [Full Text] [Related]  

  • 6. Imbalance of CD4+CD29+ and CD4+CD45RA+ T-helper cell subsets in peripheral blood of patients with severe atopic dermatitis.
    Jung K; Bittrich A; Klimmek V; Schubert H
    Arch Dermatol Res; 1993; 285(3):135-9. PubMed ID: 7684891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's New in Atopic Dermatitis.
    Renert-Yuval Y; Guttman-Yassky E
    Dermatol Clin; 2019 Apr; 37(2):205-213. PubMed ID: 30850043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell subpopulations in the development of atopic and contact allergy.
    Girolomoni G; Sebastiani S; Albanesi C; Cavani A
    Curr Opin Immunol; 2001 Dec; 13(6):733-7. PubMed ID: 11677098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosacea associated with dupilumab therapy.
    Heibel HD; Hendricks AJ; Foshee JP; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
    [No Abstract]   [Full Text] [Related]  

  • 10. [Subpopulations of peripheral T lymphocytes (Th/Ts) in atopic dermatitis and in psoriasis].
    Klene U; Gollnick H; Bauer R; Orfanos CE
    Hautarzt; 1986 Jan; 37(1):17-22. PubMed ID: 2936698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between expression of CD200 on B lymphocytes and the count of eosinophils and basophils in atopic dermatitis patients with and without dupilumab therapy - Pilot study.
    Čelakovská J; Čermákova E; Boudková P; Andrýs C; Krejsek J
    Int Immunopharmacol; 2024 May; 132():112023. PubMed ID: 38603859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis.
    Fowler E; Rosen J; Lev-Tov H; Yosipovitch G
    Acta Derm Venereol; 2019 Sep; 99(10):899-900. PubMed ID: 31037315
    [No Abstract]   [Full Text] [Related]  

  • 13. Dupilumab in the treatment of asthma.
    Grey A; Katelaris CH
    Immunotherapy; 2019 Jul; 11(10):859-872. PubMed ID: 31218914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies for the treatment of atopic dermatitis.
    Renert-Yuval Y; Guttman-Yassky E
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report.
    Ludriksone L; Elsner P; Malessa C; Settmacher U; Schliemann S
    J Dtsch Dermatol Ges; 2020 Jul; 18(7):740-742. PubMed ID: 32212242
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of CD3-dependent lymphocyte proliferation by extracellular matrix proteins in atopic dermatitis.
    Glinski W; Stepien-Sopniewska B; Korczak-Kowalska G; Glinska-Ferenz M; Gorski A
    Acta Derm Venereol; 1995 Sep; 75(5):353-6. PubMed ID: 8615050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th-17 lymphocytes.
    Wardle EN
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):954-6. PubMed ID: 20814142
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of dupilumab in the treatment of atopic diseases.
    Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
    Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
    Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
    Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of circulating lymphocyte subpopulations in atopic dermatitis using monoclonal antibodies].
    De Maubeuge J; Delespesse G; Achten G; Servais G; De Vetter L; Gaillaert N
    Dermatologica; 1984; 169(1):6-11. PubMed ID: 6236116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.